Elizabeth A. Lawson, MD

Department of Medicine, Harvard Medical School, Boston, Massachusetts; Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mass General Brigham Multidisciplinary Eating Disorder Research Collaborative, Mass General Brigham, Boston, Massachusetts

  • 12Articles
  • 56.8KReads
  • 2007–2026Active
  • 61Collaborators
  • 410Citations

About

Elizabeth A. Lawson, MD, is affiliated with the Department of Medicine at Harvard Medical School and the Neuroendocrine Unit in the Department of Medicine at Massachusetts General Hospital, both in Boston, Massachusetts. Lawson is also part of the Mass General Brigham Multidisciplinary Eating Disorder Research Collaborative. Her work, published from 2007 to 2026, focuses on eating disorders, women, and child and adolescent psychiatry.

Publications

JCP
Differential Impact of Cholecystokinin and Ghrelin on 2-Year Avoidant/Restrictive Food Intake Disorder Symptoms
Original Research

Differential Impact of Cholecystokinin and Ghrelin on 2-Year Avoidant/Restrictive Food Intake Disorder Symptoms

May 20, 2026

Decreases in CCK and increases in ghrelin were associated with improvements in ARFID symptomology.
, , , et al
JCP
Low Ghrelin and Anxiety in ARFID
Original Research

Low Ghrelin and Anxiety in ARFID

May 3, 2023

Low ghrelin levels were associated with greater anxiety in ARFID, indicating a potential target in the treatment of this disorder.
, , , et al
JCP
Elevated CCK With ARFID
Original Research

Elevated CCK With ARFID

July 11, 2022

Avoidant/restrictive food intake disorder (ARFID) is characterized by food avoidance unmotivated by body weight/shape concerns. This study explored if levels of the satiety hormone cholecystokinin are higher in individuals...
, , , et al
JCP
Original Research

Diagnostic Definitions Impact ARFID Prevalence

September 7, 2021

DSM-5 criteria for avoidant/restrictive food intake disorder (ARFID) include ambiguities that can affect access to treatment. This study looked at how differing definitions affect the number of individuals who...
, , , et al
JCP
Original Research

Ghrelin Agonist Treatment in Anorexia Nervosa

January 2, 2018

Levels of the appetite-stimulating hormone ghrelin are elevated in girls and women with anorexia nervosa. However, women with anorexia nervosa report less hunger than healthy controls—a discrepancy possibly due...
, , , et al
JCP
Article

Cognition in Amenorrheic Athletes Receiving Estrogen

March 14, 2017

Both estrogen and exercise may have cognition-enhancing benefits, but the effect of estrogen deficiency on young oligomenorrheic/amenorrheic athletes has not been evaluated. Read the article to see if this...
, , , et al
JCP
Academic Highlights

Low Oxytocin in Anorexia Nervosa in Partial Recovery

November 23, 2016

Do low oxytocin levels in patients with anorexia nervosa (AN) result from low weight, or do they persist even after recovery? To answer this question, this study measured oxytocin...
, , , et al
JCP
Original Research

Appetite Regulatory Hormones in Women With Anorexia Nervosa: Binge-Eating/Purging Versus Restricting Type

July 8, 2014

, , , et al
JCP
Article

Postprandial Oxytocin Secretion Is Associated With Severity of Anxiety and Depressive Symptoms in Anorexia Nervosa

May 15, 2013

, , , et al
JCP
Article

Plasma Sodium Level Is Associated With Bone Loss Severity in Women With Anorexia Nervosa: A Cross-Sectional Study

November 15, 2012

, , , et al
JCP
Article

Decreased Nocturnal Oxytocin Levels in Anorexia Nervosa Are Associated With Low Bone Mineral Density and Fat Mass

August 9, 2011

, , , et al
JCP
Article

Androgen Deficiency: Association With Increased Anxiety and Depression Symptom Severity in Anorexia Nervosa

June 15, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe